COMMUNIQUÉS West-GlobeNewswire

Eloxx Pharmaceuticals to Participate in the 2019 5th Annual SunTrust Robinson Humphrey (STRH) Life Sciences Summit on May 7, 2019
15/04/2019
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
Addus HomeCare Announces First-Quarter 2019 Earnings Release and Conference Call
15/04/2019
Frisco, Texas, April 15, 2019 (GLOBE NEWSWIRE) -- Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2019, on [...]
Grant of warrants
15/04/2019
April 15, 2019 Announcement no. 5 Grant of warrants Today, and in accordance with the company's Remuneration policy and guidelines for incentive-based remuneration and the authorization in section 18 of the Articles of [...]
Homology Medicines Announces Upcoming Presentations on its Gene Therapy and Gene Editing Platform and Manufacturing Capabilities at the American Society of Gene & Cell Therapy Meeting
15/04/2019
BEDFORD, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today upcoming presentations highlighting its gene therapy and gene editing platform, [...]
Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting
15/04/2019
Five oral and seven poster presentations focus on Voyager’s preclinical programs, new capsid development efforts, and manufacturing capabilities CAMBRIDGE, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics [...]
Amicus Therapeutics to Present Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting
15/04/2019
CRANBURY, N.J., April 15, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced the company will present initial preclinical data from its investigational adeno-associated viral (AAV) gene therapy [...]
Sienna Announces April Dividend
15/04/2019
MARKHAM, Ontario, April 15, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.0765 per common share of the Company (each, a “Common Share”) [...]
Athersys to Host Investor Day in New York City
15/04/2019
Special Event to be Held Tuesday, May 14, 2019 CLEVELAND, Ohio, April 15, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that the company will host an investor day on Tuesday, May 14, 2019. The [...]
Information regarding acquisition or disposal of a major holding
15/04/2019
Joint Stock Company “Grindeks” hereby informs that today, on 15 April 2019 it has received notifications of a disposal of major holding from its shareholders Kirovs Lipmans and Anna Lipmane and an acquisition of a major [...]
Konica Minolta KDR AU and KDR Primary DR Systems Receive Seismic Certification
15/04/2019
WAYNE. N.J., April 15, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., announces the KDR™ Advanced U-Arm and KDR™ Primary Digital Radiography System have been certified in California to withstand [...]
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia
15/04/2019
More Than 40% of Patients Have Completed Their 6 Month Treatment Plan Top Line Results Remain On Track For Year-End Annual Performance Grants of Stock Options and Amendment of Stock Option Plan Announced LAVAL, Quebec, [...]
Precipio Announces 2018 Year-End Corporate Update Call for Shareholders
15/04/2019
Conference Call to Be Held On Monday, May 6th, 2019 at 5:00 PM ET NEW HAVEN, Conn., April 15, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) will be hosting its 2018 year- [...]
Information regarding proposal preparation for the mandatory redemption of shares
15/04/2019
Joint Stock Company “Grindeks” hereby informs that today, on 15 April 2019 it has received the information from its shareholders Kirovs Lipmans, Anna Lipmane and Filips Lipmans that according to the agreement signed [...]
BioPorto Appoints New President of BioPorto Diagnostics, Inc.
15/04/2019
April 15, 2019 NEWS release BioPorto Appoints New President of BioPorto Diagnostics, Inc. Company Plans to Bring Novel Kidney Diagnostic to US Market Today, BioPorto A/S CPH: BIOPOR (“BioPorto”) announces the [...]
Genetic Technologies and The Translational Genomics Research Institute of Phoenix, Arizona Sign Memorandum of Understanding
15/04/2019
MELBOURNE, Australia, April 15, 2019 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE) (“Company”), a provider of world-leading genetic risk assessment test products, is pleased to announce that [...]
Alphatec Announces Sales Leadership Appointment And Successful Closing of Expanded Credit Facility With Squadron Capital
15/04/2019
Experienced Spine Executive David Sponsel Assumes Sales Leadership Role CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative [...]
Aptevo Therapeutics Reports IXINITY® and Pipeline Progress
15/04/2019
Reports 73% Increase in IXINITY Year-Over-Year Quarterly Net Revenue in Q1 2019 Anticipates Launching New IXINITY 3,000 IU Assay Mid-2019 Advances Dosing in Additional Cohorts in APVO436 and APVO210 Clinical Programs On [...]
Auris Medical Receives Positive Nasdaq Listing Determination
15/04/2019
Hamilton, Bermuda, April 15, 2019 (GLOBE NEWSWIRE) -- Hamilton, Bermuda, April 15, 2019 – Auris Medical Holding Ltd. (Nasdaq: EARS), a clinical-stage company dedicated to developing therapeutics that address important [...]
Adverum Biotechnologies Provides Clinical Program Update on ADVM-022 Gene Therapy for Wet AMD
15/04/2019
- Clinical Hold until Additional CMC Information is Reviewed by FDA - - Independent DMC Review of Safety Data from First Cohort of Six Patients with No SAEs or DLTs - - Adverum Plans to Present 24-Week Data from First [...]

Pages